Vaccine hesitancy: Not a new phenomenon, but a new threat

Koslap-Petraco, Mary Beth

doi:10.1097/jxx.0000000000000342

Cited by 29 publications

(24 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Anti-vaccination groups have always co-existed along with advances in vaccination technology [ 13 ]. More recently, the Andrew Wakefield scandal in which the research showed an association between the MMR vaccine and autism created a huge anti-vaccination sentiment and led to reduced vaccine uptake in the United States [ 14 ]. In India, vaccine hesitancy and reluctance to accept vaccines exist in significant numbers even for routine immunization.…”

Section: Introductionmentioning

confidence: 99%

Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey

Danabal

Magesh

Saravanan

et al. 2021

BMC Health Serv Res

127

View full text Add to dashboard Cite

Background Effective and safe COVID 19 vaccines have been approved for emergency use since the end of 2020 and countries are actively vaccinating their people. Nevertheless, hesitancy towards the vaccines exist globally. Objectives We conducted this study to understand the attitudes towards COVID 19 vaccines and hesitancy to accept it among urban and rural communities in Tamil Nadu, India. Methods We conducted a community based cross sectional study in urban and rural communities among 564 persons who had not been vaccinated yet, selected through multistage random sampling. The vaccine attitude scale (VAX) was used to measure attitudes towards the vaccines and their acceptance of the vaccine was captured by responses to a direct question. Results More than 50% of the respondents had positive attitudes towards the COVID 19 vaccines. Based on their attitudes, they were segmented into four clusters, first with preference for natural immunity compared to vaccines and low concern regarding adverse effects. Second with high level of trust in vaccines and low mistrust. The third cluster members had high level of concern regarding the adverse effects and low levels of mistrust in vaccines and the fourth had high trust in vaccines and low preference for natural immunity. Older individuals with higher education and occupation were more likely to belong to cluster four with high trust in the vaccines. Younger individuals, women, rural residents, belonging to low income labourer class were highly mistrusting of the vaccines. The prevalence of vaccine hesitancy was 40.7% (95% CI – 36.67 - 44.73%), while 19.5% (95% CI = 16.23 - 22.77%) of the respondents were vaccine deniers. While vaccine acceptance was greatest in cluster 1, it was least in cluster 3. Conclusions Vaccine hesitancy was high in urban and rural Tamil Nadu. The population could be effectively segmented into groups based on their attitudes and this understanding can be used to develop targeted behaviour change communication campaigns.

show abstract

Section: Introductionmentioning

confidence: 99%

Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey

Danabal

Magesh

Saravanan

et al. 2021

BMC Health Serv Res

127

View full text Add to dashboard Cite

show abstract

“…The anti-vaccination behavior of the general public has been reported previously with polio vaccination in Pakistan. This behavior was developed due to various conspiracy theories and superstitious religious beliefs of the general public regarding vaccination [ 18 , 19 , 20 , 21 ]. Amid the COVID-19 pandemic, the practice of non-pharmaceutical intervention like wearing a mask, using hand sanitizer, washing hands, and social distancing was less observed among the general population of Pakistan.…”

Section: Introductionmentioning

confidence: 99%

A National Survey to Assess the COVID-19 Vaccine-Related Conspiracy Beliefs, Acceptability, Preference, and Willingness to Pay among the General Population of Pakistan

et al. 2021

View full text Add to dashboard Cite

The current study aims to assess the beliefs of the general public in Pakistan towards conspiracy theories, acceptance, willingness to pay, and preference for the COVID-19 vaccine. A cross-sectional study was conducted through an online self-administered questionnaire during January 2021. The Chi-square test or Fisher exact test was utilized for statistical data analysis. A total of 2158 respondents completed the questionnaire, among them 1192 (55.2%) were male with 23.87 (SD: ±6.23) years as mean age. The conspiracy beliefs circulating regarding the COVID-19 vaccine were believed by 9.3% to 28.4% of the study participants. Among them, 1040 (48.2%) agreed to vaccinate on its availability while 934 (43.3%) reported the Chinese vaccine as their preference. The conspiracy beliefs of the participants were significantly associated with acceptance of the COVID-19 vaccine. The existence of conspiracy beliefs and low vaccine acceptance among the general population is a serious threat to successful COVID-19 vaccination.

show abstract

“…3 The threat of vaccine hesitancy persists despite significant clinical data supporting the benefit and importance of vaccinations in disease prevention. 4,5 In 2019, WHO classified vaccine hesitancy as a top 10 global health threat, alongside other major concerns such as the Ebola virus, HIV, and climate change. 6 Social media has contributed to this crisis by facilitating the promotion of information that is inaccurate, is not based in scientific evidence, or may increase patient uncertainty, anxiety, or hesitancy toward vaccination.…”

Section: Purposementioning

confidence: 99%

Extent of and Reasons for Vaccine Hesitancy in Adults at High-Risk for Pneumococcal Disease

et al. 2021

View full text Add to dashboard Cite

Purpose: To determine the extent of and reasons for hesitancy toward vaccination among adults at high-risk for pneumococcal disease. Design: Cross-sectional. Setting: Online survey in March-April 2019 via QuestionPro. Subjects: Tennessee adults (18-64 years) at high-risk of pneumococcal disease (n = 1,002). Measures: Modified version of the validated Vaccine Hesitancy Scale assessed vaccine-related beliefs, reasons for hesitancy, external influences on vaccination, and prior vaccination Analysis: Descriptive and inferential statistics provided an overview of the responses and comparisons among subgroups. Logistic regression determined the odds of being hesitant using the listed beliefs and influencers as predictors. Thematic analysis was performed on the qualitative data gathered from free response questions throughout the survey. Results: Analysis included 1,002 complete responses (12% response rate [total viewed = 8,331]) with 34.3% indicating hesitancy toward one or more recommended vaccinations, with 53% of which indicating hesitancy to the pneumococcal vaccine despite it being recommended by the Advisory Committee on Immunization Practices (ACIP) for all respondents. The odds of vaccine hesitancy or resistance were higher in minorities (OR: 1.6; 95% CI: 1.19-2.11), those not believing others like them get vaccinated (OR: 1.82; 95% CI: 1.262-2.613), and respondents recalling negative media about vaccines (OR: 2.56; 95% CI: 1.797-3.643). Conclusions: Patients at high-risk of pneumococcal disease lack awareness of the need for the recommended vaccine, and provider education may need improving to increase vaccination in this population.

show abstract

Vaccine hesitancy: Not a new phenomenon, but a new threat

Cited by 29 publications

References 8 publications

Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey

Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey

A National Survey to Assess the COVID-19 Vaccine-Related Conspiracy Beliefs, Acceptability, Preference, and Willingness to Pay among the General Population of Pakistan

Extent of and Reasons for Vaccine Hesitancy in Adults at High-Risk for Pneumococcal Disease

Contact Info

Product

Resources

About